Theracryf Share Discussion Threads

[hamidahamida] 19/2/2025 13:14:08

A Grave Concern: Dr. Alistair Smith's Appointment & A History of Value Destruction. He arrives at a new post, and DEJA VU strikes: ...deeply discounted placing...already on the table. Coincidence? --The appointment of Dr. Alistair Smith raises urgent questions about judgment, accountability, and the safeguarding of shareholder value. Let's be blunt: ...his track record speaks for itself.....At Avacta plc, Smith presided over a reckless acquisition spree, overpaying for assets that now sit as dead weight-unable to be sold, unable to generate returns. His tenure was defined by ...value destruction.... not creation. Shareholders bore the cost of his poor business sense, watching capital evaporate as he chased deals at inflated prices. The result? A legacy of financial strain and a resignation that reeked of failure, not foresight. Now, he arrives at a new post, and déjà vu strikes: ...deeply discounted placings...are already on the table. Coincidence? Or a pattern of favoring short-term financial maneuvers over long-term stability? Discounted placings dilute existing shareholders, rewarding failure while punishing those who stay loyal. Demand accountability. Scrutinize this appointment.

[andymunchkin] 19/2/2025 13:12:43

markth12629 Apr '24 - 08:29 - 1 of 238
0 3 0
Hello old EVGers - hopefully we can have some sensible discussion over here now and see some green shoots of hope coming out of the company soon.
-----
thiopia19 Feb '25 - 12:50 - 237 of 238
0 0 0
Absolute scumbags
----
Whers mOneYmUnching hO???

[thunderchicken] 19/2/2025 13:09:21

Thanks for anticipating my next move clocktower. I was just about to ask if anyone has calculated Mr Kight's losses on this pile of poo, and you beat me to it.

[clocktower] 19/2/2025 13:01:35

I was just thinking about J R Kight he must have invested almost £1 million and now that is worth at best less than £90k - that must hurt having been diluted to that extent.

Good Luck Paddyfool if you are buying now but with the history of this company I think you might need it unless they get lucky.

[paddyfool] 19/2/2025 12:51:51

great investment at this level though.

[thiopia] 19/2/2025 12:50:23

Absolute scumbags

[clocktower] 19/2/2025 12:03:27

Next they might tell you they have got funds from Stalicla to get things off to a good start.

Those Huw sucked in at 1p will not be happy bunnies.

The only ones that now stand to maker a huge profit are those funding at .0025

Huw and his mates get to get their salaries rolling.

Big fast fees being picked up, worse than Thames Water maybe?

[darmz] 19/2/2025 11:38:13

Excellent news

[dave4545] 19/2/2025 11:34:42

It's just as much as a disgrace they issued some positive news first then the placing 10 mins later.

[teaboy100] 19/2/2025 11:28:48

A real train wreck, this company.

[washingmachine] 19/2/2025 11:24:33

Wow
Remember buying this at 8 pence
Absolute disgrace

[markth126] 19/2/2025 11:08:51

utter disgrace¬¬!

[thiopia] 03/2/2025 17:50:10

free stock charts from uk.advfn.com

[dave4545] 31/1/2025 14:11:07

wow that is more like it and full 1.1p to buy now

Thought they were playing around with little stock and this confirms it.

[dave4545] 31/1/2025 13:30:21

All 6 mm's are 0.8p and there has been 6 buys above 0.93p and none one of them will go 0.85p

Total greed atm

[clocktower] 30/1/2025 15:14:10

Thought this might interest a few of you that might still be holding an, and may explain the recent rise.

Good Luck. I am no longer trading.

//informaconnect.com/bioeurope-spring/sponsors/stalicla-sa/


"Stalicla is a precision neuro clinical stage company. Funded in 2017, Stalicla has raised over $80m in private capital and non dilutive funding. Stalicla’s shareholders include Novartis, Pitcted, Edmmond de Rothschild and SPRIM. Stalicla has successfully developed a unique neuro platform, DEPI, with a first application in precsion Autism Sepctrum Disorder through the clinical development of 2 precision autism assets: STP1 and STP2 entering Phase 2. Stalicla has also developed a mGluR5 NAM platform with its lead asset, STP7 (mavoglurant) licensed from Novartis, entering Phase III in partnership with the National Insitute of Health. Stalicla mGluR5 platform offers multi-faceted late-stage clinical development opportunities in the field of CNS. STALICLA is now preparing a 65m-Series C to support STP1 & STP2 phase 2, develop STP7 around substance use disorders and additional CNS indications and expend its neuro precision pipeline through the in licensing and development of a new PhII asset for which Stalicla has already secured a $24m of credit line."

[dave4545] 30/1/2025 10:01:54

300k buy after at 0.934p the spread is ridiculous

[dave4545] 30/1/2025 09:47:44

Somebody sold at 0.816p when 2 days earlier people were buying at 1.1p high

Nuts, mm's happy though

[hairballradical] 28/1/2025 14:31:13

Come on The Ratcliff, its not just for posh people.

[dave4545] 28/1/2025 11:23:10

Somebody keeps nibbling all the way up

[dave4545] 28/1/2025 11:07:19

0.55p was a nice price now eh

[peterm10] 15/1/2025 16:58:36

Just tuned in, nice surprise

[dave4545] 15/1/2025 14:13:54

Sector bubbling since TRLS spike

[darmz] 15/1/2025 13:55:29

Feels like placing